1.
Question 1
All of the following are required for a U.S. FDA New Drug Application EXCEPT:
1 point
Preclinical data
Packaging methods
Disclosure of intent to file in other countries
Human bioavailability
1.
Question 1
All of the following are required for a U.S. FDA New Drug Application EXCEPT:
1 point
Preclinical data
Packaging methods
Disclosure of intent to file in other countries
Human bioavailability